EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Understanding Inflammatory Bowel Disease: An Integrative Framework of Microbiome, Metabolome, and Immunological Biomarkers

Prithvi S. Prabhu, Rija Kalita, Vanshika Sharma, Tulika Prakash

Journal of Translational Gastroenterology · 25.03.2025 · 000 (000) · 000-000

DOI: 10.14218/jtg.2024.00030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Translational Gastroenterology, online erschienen am 25.03.2025. Verfasst von Prithvi S. Prabhu und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is characterized by chronic inflammation of the gastrointestinal tract and primarily includes ulcerative colitis and Crohn’s disease. As the number of patients suffering from IBD increases, diagnosis and treatment have become pressing yet challenging tasks. A major challenge is that patients with IBD often do not exhibit characteristic symptoms, making it difficult to distinguish IBD from other intestinal abnormalities. Endoscopy is the most conventional method used to diagnose IBD; however, this technique is invasive and costly. Therefore, there is a need to develop affordable, non-invasive diagnostic methods, which underscores the importance of identifying biomarkers specific to IBD. It is now well established that the gut microbiome plays a significant role in the development of IBD, and changes in the abundance of various gut organisms have been widely studied to identify microbial signatures associated with the disease. This review discusses the current state of knowledge regarding biomarkers in IBD, with a primary focus on the gut microbiome, associated metabolic signatures, and their links with immunological biomarkers. These biomarkers will help propose an integrative model to better understand the pathophysiology of this complex disease. Such an integrated approach also offers insights into potential therapeutic targets for designing more effective treatment strategies for patients.

Zitieren

APA

Prabhu, P. S., Kalita, R., Sharma, V., & Prakash, T. (2025). Understanding Inflammatory Bowel Disease: An Integrative Framework of Microbiome, Metabolome, and Immunological Biomarkers. Journal of Translational Gastroenterology, 000(000), 000-000. https://doi.org/10.14218/jtg.2024.00030

Vancouver

Prabhu PS, Kalita R, Sharma V, Prakash T. Understanding Inflammatory Bowel Disease: An Integrative Framework of Microbiome, Metabolome, and Immunological Biomarkers. Journal of Translational Gastroenterology. 2025;000(000):000-000. doi:10.14218/jtg.2024.00030

BibTeX
@article{Prabhu2025,
  author = {Prabhu, Prithvi S. and Kalita, Rija and Sharma, Vanshika and Prakash, Tulika},
  title = {Understanding Inflammatory Bowel Disease: An Integrative Framework of Microbiome, Metabolome, and Immunological Biomarkers},
  journal = {Journal of Translational Gastroenterology},
  year = {2025},
  volume = {000},
  number = {000},
  pages = {000--000},
  doi = {10.14218/jtg.2024.00030}
}
Kostenlos starten →